Strongly interacting quantum particles are key to some of the most fascinating phenomena in modern physics—from magnetism and ...

AlzeCure Pharma AB, a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the last patient’s last ...

Good day, and thank you for standing by. Welcome to the ORIC Enozertinib Program Update Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would ...

Good day, and welcome to the TX45 Phase Ib Part B PH-HFrEF data conference call. [Operator Instructions] As a reminder, this call may be recorded. I would now like to turn the call over to Dr. Alise ...

DeLLphi-303 Phase Ib trial results demonstrate acceptable safety profile, unprecedented survival in ES-SCLC by International Association for the Study of Lung Cancer edited by Sadie Harley, reviewed ...

ONITT: A phase I study of nanoliposomal irinotecan with talazoparib or temozolomide in children and young adults with recurrent or refractory solid tumors. Promoting Resilience in Stress Management ...

BASEL, Switzerland – 29 April 2025 – Nouscom, a clinical-stage biotech company developing next-generation neoantigen-targeted off-the-shelf and personalized cancer immunotherapies, today announced ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Physicists with the U.S. Department of Energy have discovered a new ...

Forbes contributors publish independent expert analyses and insights. I write on the human/political issues surrounding college admissions. Two young male students investigate a project at a science ...

Combining concepts from statistical physics with machine learning, researchers at the University of Bayreuth have shown that highly accurate and efficient predictions can now be made as to whether a ...